logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Phenylketonurias

    Medications for Phenylketonurias

    FiltersReset Filters
    5 results

    • palynziq

      (pegvaliase-pqpz)
      BioMarin Pharmaceutical Inc.
      Usage: Palynziq is indicated for reducing blood phenylalanine levels in adult patients with phenylketonuria (PKU) who have uncontrolled concentrations above 600 micromol/L despite current treatment.

    • sapropterin dihydrochloride

      (Sapropterin dihydrochloride)
      NorthStar RxLLC
      Usage: Sapropterin dihydrochloride is indicated to reduce blood phenylalanine levels in patients aged one month and older with hyperphenylalaninemia due to tetrahydrobiopterin-responsive phenylketonuria. It is used alongside a phenylalanine-restricted diet.

    • sapropterin dihydrochloride

      (sapropterin dihydrochloride)
      NorthStar RxLLC
      Usage: Sapropterin dihydrochloride tablets are indicated for reducing blood phenylalanine levels in patients aged one month and older with hyperphenylalaninemia due to tetrahydrobiopterin-responsive Phenylketonuria. It is to be used alongside a phenylalanine-restricted diet.

    • sapropterin dihydrochloride

      (SAPROPTERIN DIHYDROCHLORIDE)
      ENDO USA, Inc.
      Usage: Sapropterin dihydrochloride is indicated for reducing blood phenylalanine levels in patients aged one month and older with hyperphenylalaninemia due to tetrahydrobiopterin-responsive Phenylketonuria. It should be used alongside a phenylalanine-restricted diet.

    • sephience

      (sepiapterin)
      PTC Therapeutics Inc.
      Usage: SEPHIENCE is indicated for treating hyperphenylalaninemia in patients aged 1 month and older with sepiapterin-responsive phenylketonuria. It should be used alongside a phenylalanine-restricted diet.